Serum proteome of dogs with chronic enteropathy
Journal of Veterinary Internal Medicine · 01.05.2023 · 37 (3) · 925-935
DOI: 10.1111/jvim.16682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 01.05.2023. Verfasst von Jane Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sydney School of Veterinary Science, Faculty of Science, The University of Sydney, Sydney, New South Wales, 2006, Australia. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Dog Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Betty and Keith Cook Canine Research Fund.
Abstract (Originalsprache)
Background
Chronic enteropathy (CE) is common in dogs and can occur with multiple etiologies including food-responsive enteropathy (FRE) and idiopathic inflammatory bowel disease (IBD). Hypothesis/Objective To study the protein profile and pathway differences among dogs with FRE, IBD, and healthy controls using serum proteome analysis. Animals Nine CE dogs with signs of gastrointestinal disease and histologically confirmed chronic inflammatory enteropathy and 16 healthy controls.
Methods
A cross-sectional study with cases recruited from 2 veterinary hospitals between May 2019 and November 2020 was performed. Serum samples were analyzed using mass spectrometry-based proteomic techniques.
Results
Proteomic profiles showed marked variation in relative protein abundances. Forty-five proteins were significantly (P ≤ .01) differentially expressed among the dogs with CE and controls with ≥2-fold change in abundance. The fold change of dogs with IBD normalized to controls was more pronounced for the majority of proteins than that seen in the dogs with FRE normalized to control dogs. Proteins involving reactive oxygen species, cytokine activation, acute phase response signaling, and lipid metabolism were altered in dogs with CE. Conclusions and Clinical Importance Cytokine alterations, acute phase response signaling, and lipid metabolism are likely involved in pathogenesis of CE. Although there are insufficient current data to justify the use of proteomic biomarkers for assessment of CE in dogs, our study identifies potential candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sydney School of Veterinary Science, Faculty of Science, The University of Sydney, Sydney, New South Wales, 2006, Australia.
- McIvor Road Veterinary Centre, Bendigo, Victoria, Australia.
- Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, New South Wales, Australia.
ORCID-Profile: Jane Yu, Craig Ruaux, Peter Bennett
Förderung
- Betty and Keith Cook Canine Research Fund
Zitieren
APA
Yu, J., Ruaux, C., Griebsch, C., Boland, L., Wong, N., Bennett, P., & Wasinger, V. C. (2023). Serum proteome of dogs with chronic enteropathy. Journal of Veterinary Internal Medicine, 37(3), 925-935. https://doi.org/10.1111/jvim.16682
Vancouver
Yu J, Ruaux C, Griebsch C, Boland L, Wong N, Bennett P, et al. Serum proteome of dogs with chronic enteropathy. Journal of Veterinary Internal Medicine. 2023;37(3):925-935. doi:10.1111/jvim.16682
BibTeX
@article{Yu2023,
author = {Yu, Jane and Ruaux, Craig and Griebsch, Christine and Boland, Lara and Wong, Nadia and Bennett, Peter and Wasinger, Valerie C},
title = {Serum proteome of dogs with chronic enteropathy},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
volume = {37},
number = {3},
pages = {925--935},
doi = {10.1111/jvim.16682}
}
EUVIMED